Chin-Bin Yeh
Tri-Service General Hospital (TSGH) · Tri-Service General Hospital, National Defense Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Chin-Bin Yeh as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:13 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07382843 · Melatonin Agonist for Shift-time Workers.Tri-Service General Hospital (TSGH) · completed · Circadian Rhythm Disorders · principal investigator
- Ph4NCT05974241 · Irritability in Children With ADHD and Emotion DysregulationTri-Service General Hospital (TSGH) · completed · Irritable Mood, ADHD · principal investigator
- Ph4NCT05043805 · Dextromethorphan Added on for Children With Chronic IrritabilityTri-Service General Hospital (TSGH) · completed · Irritable Mood · principal investigator
- N/ANCT03358277 · Aripiprazole Added on for DMDD in Youths With ADHDTri-Service General Hospital (TSGH) · completed · Disruptive Mood Dysregulation Disorder · principal investigator
- Ph2NCT02473783 · The Serotonin Transporter Availability for Prognosing Major Depressive Disorder (MDD) Treatment and Detecting MDDTri-Service General Hospital (TSGH) · completed · Major Depressive Disorder · principal investigator
- Ph3NCT02142556 · The Efficacy and Safety of Quetiapine XR in Patients With Schizophrenia Switched From Other AntipsychoticsTri-Service General Hospital (TSGH) · completed · Schizophrenia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:13 UTC. The ranking covers the 200 most relevant of 212 PubMed records, and a shared surname and initials can bring in a namesake. All 212 on PubMed
- Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy.Hepatology · 1999450 citationsRCR 12.7
- Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.Am J Gastroenterol · 2005225 citationsRCR 6.6
- 187 citationsRCR 6.9
- Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study.Dis Colon Rectum · 2008173 citationsRCR 6.7
- Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.Gastroenterology · 2009129 citationsRCR 4.1
- Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial.Can J Gastroenterol · 2007128 citationsRCR 3.9
- A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer.Br J Cancer · 2013127 citationsRCR 3.7
- Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.J Clin Psychiatry · 2000121 citationsRCR 4.7
- Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial.High Alt Med Biol · 2003113 citationsRCR 3.7
- Efficacy of thymosin alpha1 in patients with chronic hepatitis B: a randomized, controlled trial.Hepatology · 1998111 citationsRCR 3.0